Therefore, first of all, we investigated the nature of ameloblastomas using the classic and revised neuroendocrine markers, CD56, SYP, CgA, and INSM1, as well as the correlation between CLU and the expression of neuroendocrine markers. This evidence concerns the gene NCAM1 and ameloblastoma.